Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2026-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$188.7m reported value -13.4% vs Q4 2025
37positions
59.8%in top 10
8 new 3 added 3 reduced 4 sold out vs Q4 2025

Holdings, Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 2,328,602 $19.7m10.44% 10.44% UnchangedShares held: Q2 2025 895.3k, Q3 2025 895.3k, Q4 2025 2.3m, Q1 2026 2.3m
2 SPROTT PHYSICAL GOLD TR UNIT PHYS PHYS 387,055 $13.7m7.27% 7.27% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 387.1k
3 ROYAL GOLD INC COM RGLD RGLD 52,750 $13.4m7.11% 7.11% UnchangedShares held: Q2 2025 9.0k, Q3 2025 9.0k, Q4 2025 52.8k, Q1 2026 52.8k
4 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,250,000 $10.8m5.74% 5.74% UnchangedShares held: Q2 2025 1.2m, Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.2m
5 AGNICO EAGLE MINES LTD COM AEM AEM 52,750 $10.7m5.67% 5.67% UnchangedShares held: Q2 2025 55.5k, Q3 2025 52.8k, Q4 2025 52.8k, Q1 2026 52.8k
6 KINROSS GOLD CORP COM KGC KGC 320,000 $9.8m5.18% 5.18% ReducedShares held: Q2 2025 440.0k, Q3 2025 410.0k, Q4 2025 410.0k, Q1 2026 320.0k -90.0k -90,000 -21.9%
7 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $9.3m4.90% 4.90% UnchangedShares held: Q2 2025 5.5m, Q3 2025 5.5m, Q4 2025 5.5m, Q1 2026 5.5m
8 SEABRIDGE GOLD INC COM COM 317,003 $9.0m4.76% 4.76% UnchangedShares held: Q2 2025 317.0k, Q3 2025 317.0k, Q4 2025 317.0k, Q1 2026 317.0k
9 OR ROYALTIES INC. COM SHS OR OR 225,000 $8.6m4.53% 4.53% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 225.0k
10 FRANCO NEV CORP COM FNV FNV 32,000 $7.9m4.19% 4.19% AddedShares held: Q2 2025 25.0k, Q3 2025 25.0k, Q4 2025 25.0k, Q1 2026 32.0k +7.0k +7,000 28.0%
11 SSR MINING IN COM SSRM SSRM 245,000 $7.2m3.82% 3.82% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 245.0k, Q1 2026 245.0k
12 ELICIO THERAPEUTICS INC COM ELTX ELTX 630,915 $6.7m3.57% 3.57% UnchangedShares held: Q2 2025 630.9k, Q3 2025 630.9k, Q4 2025 630.9k, Q1 2026 630.9k
13 ENTERA BIO LTD SHS ENTX ENTX 5,881,879 $6.5m3.43% 3.43% UnchangedShares held: Q2 2025 5.9m, Q3 2025 5.9m, Q4 2025 5.9m, Q1 2026 5.9m
14 NUVATION BIO INC COM CL A NUVB NUVB 1,498,591 $6.4m3.41% 3.41% UnchangedShares held: Q2 2025 1.0m, Q3 2025 1.0m, Q4 2025 1.5m, Q1 2026 1.5m
15 CENTERRA GOLD INC COM CGAU CGAU 359,000 $6.4m3.38% 3.38% ReducedShares held: Q2 2025 1.2m, Q3 2025 497.4k, Q4 2025 497.4k, Q1 2026 359.0k -138.4k -138,402 -27.8%
16 PAN AMERN SILVER CORP COM PAAS PAAS 100,035 $5.5m2.90% 2.90% UnchangedShares held: Q2 2025 0, Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 100.0k
17 SPROTT PHYSICAL SILVER TR TR UNIT PSLV PSLV 222,160 $5.4m2.87% 2.87% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 222.2k
18 OCULAR THERAPEUTIX INC COM OCUL OCUL 600,400 $5.1m2.69% 2.69% UnchangedShares held: Q2 2025 600.4k, Q3 2025 600.4k, Q4 2025 600.4k, Q1 2026 600.4k
19 TRIPLE FLAG PRECIOUS METAL COM TFPM TFPM 115,000 $4.0m2.12% 2.12% AddedShares held: Q2 2025 0, Q3 2025 58.8k, Q4 2025 58.8k, Q1 2026 115.0k +56.2k +56,200 95.6%
20 GOLD ROYALTY CORP COMMON SHARES GROY GROY 1,000,000 $3.6m1.90% 1.90% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 1.0m
21 ALAMOS GOLD INC NEW COM CL A AGI AGI 50,000 $2.2m1.18% 1.18% UnchangedShares held: Q2 2025 50.0k, Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k
22 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 485,515 $2.2m1.15% 1.15% AddedShares held: Q2 2025 62.7k, Q3 2025 62.7k, Q4 2025 236.0k, Q1 2026 485.5k +249.6k +249,562 105.8%
23 NEW PAC METALS CORP COM NEWP NEWP 485,000 $2.0m1.06% 1.06% UnchangedShares held: Q2 2025 485.0k, Q3 2025 485.0k, Q4 2025 485.0k, Q1 2026 485.0k
24 COEUR MNG INC COM NEW CDE CDE 96,132 $1.8m0.96% 0.96% UnchangedShares held: Q2 2025 96.1k, Q3 2025 96.1k, Q4 2025 96.1k, Q1 2026 96.1k
25 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.7m0.89% 0.89% UnchangedShares held: Q2 2025 7.7k, Q3 2025 7.7k, Q4 2025 7.7k, Q1 2026 7.7k
26 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.7m0.88% 0.88% UnchangedShares held: Q2 2025 10.0k, Q3 2025 10.0k, Q4 2025 10.0k, Q1 2026 10.0k
27 WHEATON PRECIOUS METALS CORP COM WPM WPM 12,500 $1.6m0.87% 0.87% UnchangedShares held: Q2 2025 12.5k, Q3 2025 12.5k, Q4 2025 12.5k, Q1 2026 12.5k
28 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.5m0.78% 0.78% UnchangedShares held: Q2 2025 2.2k, Q3 2025 2.2k, Q4 2025 2.2k, Q1 2026 2.2k
29 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.0m0.54% 0.54% UnchangedShares held: Q2 2025 13.0k, Q3 2025 13.0k, Q4 2025 13.0k, Q1 2026 13.0k
30 ELEMENTAL RTY CORP COM NEW ELE ELE 50,000 $943.0k0.50% 0.50% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 50.0k
31 VERSAMET ROYALTIES CORP COM NEW VMET VMET 66,621 $633.6k0.34% 0.34% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 66.6k
32 DAKOTA GOLD CORP COM DC DC 122,921 $620.8k0.33% 0.33% UnchangedShares held: Q2 2025 0, Q3 2025 122.9k, Q4 2025 122.9k, Q1 2026 122.9k
33 AMRIZE LTD SHS AMRZ AMRZ 9,175 $514.0k0.27% 0.27% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 9.2k
34 ALTIMMUNE INC COM NEW ALT ALT 160,000 $492.8k0.26% 0.26% ReducedShares held: Q2 2025 1.1m, Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 160.0k -961.5k -961,524 -85.7%
35 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 100,000 $135.0k0.07% 0.07% UnchangedShares held: Q2 2025 100.0k, Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 100.0k
36 PHARMING GROUP NV SPON ADS PHAR PHAR 4,057 $67.5k0.04% 0.04% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 4.1k
37 Orgenesis, Inc. COM COM 50,623 $30.4k0.02% 0.02% UnchangedShares held: Q2 2025 50.6k, Q3 2025 50.6k, Q4 2025 50.6k, Q1 2026 50.6k

Sold out since Q4 2025

SecurityTickerShares held beforeValue then
AVADEL PHARMACEUTICALS PLC 600,000 $12.9m600.0k shares
SPDR GOLD TR GLD GLD 32,000 $12.7m32.0k shares
ISHARES SILVER TR SLV SLV 80,000 $5.2m80.0k shares
APPLIED THERAPEUTICS INC APLT APLT 6,050,000 $605.0k6.0m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08